Conclusion:Gefitinib is safe and effective in the treatment of patients who have advanced NSCLC or need re-treatment.
结论:吉非替尼治疗复治、晚期NSCLC患者是安全、有效的。
参考来源 - 吉非替尼治疗复治、晚期非小细胞肺癌的临床分析·2,447,543篇论文数据，部分数据来源于NoteExpress
Conclusion Both ITP and NP regimens are effective for the advanced NSCLC.
结论ITP和NP方案是治疗晚期NSCLC较有效的方案。
This information warrants further investigation of subpopulations in treatment of advanced NSCLC.
这些信息使进一步调查晚期非小细胞肺癌治疗亚组成为有理由的。
Conclusion The combined regimens of NP, nc and TC are effective and well-tolerated regimens for elder advanced NSCLC.
结论NP、NC、TC联合方案是治疗老年晚期NSCLC有效且耐受性较好的方案。
应用推荐